Profound Medical

Profound Medical Corp. is a medical technology company headquartered in Mississauga, Canada, that specializes in developing innovative, incision-free therapeutic systems for image-guided ablation of diseased tissue. The company primarily focuses on the treatment of prostate disease, uterine fibroids, and palliative pain associated with bone metastases. Its flagship product, the TULSA-PRO system, integrates real-time magnetic resonance imaging with robotically driven thermal ultrasound to provide precise ablation of prostate tissue, utilizing existing MRI infrastructure in hospitals and treatment facilities. Additionally, Profound Medical offers the Sonalleve platform, which targets uterine fibroids and bone metastases. The company collaborates with GE Healthcare to enhance access to its TULSA-PRO technology, aiming to provide safe and effective treatment options that enable patients to quickly resume their daily activities.